Key Points

• WHO warns that drug-resistant infections are spreading fast.

• Global health systems risk collapse without urgent intervention.

• Investment in new antibiotics is urgently needed.

The World Health Organization (WHO) has sounded a renewed alarm over the rapid spread of drug-resistant bacterial infections, warning that growing antimicrobial resistance could drag modern medicine into a post-antibiotic era.

New data from WHO’s 2025 Global Antimicrobial Resistance Surveillance Report show that several common infections — including pneumonia, bloodstream infections, and urinary tract infections — are becoming increasingly resistant to available antibiotics.

The trend, the organization said, is most severe in low- and middle-income countries, where self-medication, poor regulation, and inconsistent access to quality healthcare continue to fuel the problem.

Drug-resistant infections pose rising global threat

According to a report by the Punch news, Dr. Tedros Adhanom Ghebreyesus, WHO’s Director-General, called the rise of antimicrobial resistance (AMR) “a silent pandemic” that is spreading faster than governments can respond to. “Drug-resistant infections are spreading faster than we can contain them,” he said. “We are already seeing cases where no existing antibiotic works.”

The agency reports that resistance levels have climbed by almost 20 percent in some regions since 2020. Infections caused by Escherichia coli and Klebsiella pneumoniae — two major bacterial pathogens associated with hospitals — have shown particularly steep increases in resistance, undermining standard treatment options.

WHO warned that unless urgent global action is taken, the world could face a situation where minor infections once easily treated become deadly again.

WHO urges action on drug-resistant infections

In its latest report, WHO urged governments to invest in antibiotic research and strengthen regulations around the use of antimicrobial drugs in humans and animals. The organization also called for more rigorous national surveillance systems to track resistance trends and monitor antibiotic misuse.

Dr. Ramanan Laxminarayan, Director of the Center for Disease Dynamics, Economics & Policy (CDDEP), said the warning from WHO is not new but “the numbers this time are starker than ever.” He added, “We’ve been warning for years that antibiotic overuse would backfire. It’s no longer a projection — it’s happening now.”

The report also noted that fewer than 20 new antibiotics are in late-stage clinical development globally, far below what is needed to keep pace with evolving bacterial mutations.

Global response needed to contain resistance spread

Health economists estimate that unchecked drug-resistant infections could cause 10 million deaths per year by 2050 and drain up to $100 trillion from the global economy.

WHO urged countries to improve hygiene and sanitation standards, strengthen infection control in hospitals, and promote responsible antibiotic use among healthcare workers and the public.

“The fight against antimicrobial resistance is really a fight to protect the foundation of modern medicine,” Dr. Tedros said. “Every delay increases the risk of losing treatments we take for granted.”